Gender-specific impact of personal health parameters on individual brain aging in cognitively unimpaired elderly subjects

Frontiers in Aging Neuroscience

Volumn 6, Issue MAY, 2014, Pages

  Franke, Katja ^a   Ristow, Michael ^b,c   Gaser, Christian ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c ETH ZURICH   (Switzerland)

Author keywords

Aging; Alzheimer's disease (AD); BrainAGE; Lifestyle; Magnetic resonance imaging (MRI); voxel based morphometry (VBM)

Indexed keywords

CYANOCOBALAMIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN AGE GAP ESTIMATION SCORE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; SCORING SYSTEM; SEX DIFFERENCE;

EID: 84987677760     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00094     Document Type: Article

References (81)

1. Aisen, P. S., Schneider, L. S., Sano, M., Diaz-Arrastia, R., Van Dyck, C. H., Weiner, M. F., et al. (2008). High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300, 1774-1783. doi: 10.1001/jama.300.15.1774
2. Ashburner, J., Csernansky, J. G., Davatzikos, C., Fox, N. C., Frisoni, G. B., and Thompson, P. M. (2003). Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol. 2, 79-88. doi: 10.1016/S1474-4422(03)00304-1
3. Ashburner, J., and Friston, K. J. (2005). Unified segmentation. Neuroimage 26, 839-851. doi: 10.1016/j.neuroimage.2005.02.018
4. Azad, N. A., Al Bugami, M., and Loy-English, I. (2007). Gender differences in dementia risk factors. Gend. Med. 4, 120-129. doi: 10.1016/S1550-8579(07)80026-X
5. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007). Forecasting the global burden of Alzheimer's disease. Alzheimers. Dement. 3, 186-191. doi: 10.1016/j.jalz.2007.04.381
6. Cao, K., Chen-Plotkin, A. S., Plotkin, J. B., and Wang, L. S. (2010). Age-correlated gene expression in normal and neurodegenerative human brain tissues. PLoS ONE 5:e13098. doi: 10.1371/journal.pone.0013098
7. Chen, J. H., Lin, K. P., and Chen, Y. C. (2009). Risk factors for dementia. J. Formosan Med. Assoc. 108, 754-764. doi: 10.1016/S0929-6646(09)60402-2
8. Clark, V. H., Resnick, S. M., Doshi, J., Beason-Held, L. L., Zhou, Y., Ferucci, L., et al. (2012). Longitudinal imaging pattern analysis (SPARE-CD index) detects early structural and functional changes before cognitive decline in healthy older adults. Neurobiol. Aging 33, 2733-2745. doi: 10.1016/j.neurobiolaging.2012.01.010
9. Clarke, R. (2006). Vitamin B12, folic acid, and the prevention of dementia. N. Engl. J. Med. 354, 2817-2819. doi: 10.1056/NEJMe068086
10. Clarke, R., Birks, J., Nexo, E., Ueland, P. M., Schneede, J., Scott, J., et al. (2007). Low vitamin B-12 status and risk of cognitive decline in older adults. Am. J. Clin. Nutr. 86, 1384-1391.
11. Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., and Ueland, P. M. (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55, 1449-1455. doi: 10.1001/archneur.55.11.1449
12. Cockrell, J. R., and Folstein, M. F. (1988). Mini-mental state examination (MMSE). Psychopharmacol. Bull. 24, 689-692.
13. Cuadra, M. B., Cammoun, L., Butz, T., Cuisenaire, O., and Thiran, J. P. (2005). Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans. Med. Imaging 24, 1548-1565. doi: 10.1109/TMI.2005.857652
14. Czapski, G. A., Maruszak, A., Styczynska, M., Zekanowski, C., Safranow, K., and Strosznajder, J. B. (2012). Association between plasma biomarkers, CDK5 polymorphism and the risk of Alzheimer's disease. Acta Neurobiol. Exp. (Wars). 72, 397-411.
15. Debette, S., Beiser, A., Hoffmann, U., Decarli, C., O'donnell, C. J., Massaro, J. M., et al. (2010). Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann. Neurol. 68, 136-144. doi: 10.1002/ana.22062
16. Douaud, G., Refsum, H., De Jager, C. A., Jacoby, R., Nichols, T. E., Smith, S. M., et al. (2013). Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. U.S.A. 110, 9523-9528. doi: 10.1073/pnas.1301816110
17. Driscoll, I., Davatzikos, C., An, Y., Wu, X., Shen, D., Kraut, M., et al. (2009). Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 72, 1906-1913. doi: 10.1212/WNL.0b013e3181a82634
18. Dukart, J., Kherif, F., Mueller, K., Adaszewski, S., Schroeter, M. L., Frackowiak, R. S., et al. (2013a). Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease. PLoS Comput. Biol. 9:e1002987. doi: 10.1371/journal.pcbi.1002987
19. Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., et al. (2013b). Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease. Neuroimage Clin 3, 84-94. doi: 10.1016/j.nicl.2013.07.005
20. Dukart, J., Schroeter, M. L., and Mueller, K. (2011). Age correction in dementia-matching to a healthy brain. PLoS ONE 6:e22193. doi: 10.1371/journal.pone.0022193
21. Ellinson, M., Thomas, J., and Patterson, A. (2004). A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J. Hum. Nutr. Diet. 17, 371-383. doi: 10.1111/j.1365-277X.2004.00532.x
22. Enzinger, C., Fazekas, F., Matthews, P. M., Ropele, S., Schmidt, H., Smith, S., et al. (2005). Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 64, 1704-1711. doi: 10.1212/01.WNL.0000161871.83614.BB
23. Erickson, K. I., Raji, C. A., Lopez, O. L., Becker, J. T., Rosano, C., Newman, A. B., et al. (2010). Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology 75, 1415-1422. doi: 10.1212/WNL.0b013e3181f88359
24. Feart, C., Samieri, C., and Barberger-Gateau, P. (2010). Mediterranean diet and cognitive function in older adults. Curr. Opin. Clin. Nutr. Metab. Care 13, 14-18. doi: 10.1097/MCO.0b013e3283331fe4
25. Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Diehr, P., O'Meara, E. S., Longstreth, W. T., et al. (2009). Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch. Neurol. 66, 336-342. doi: 10.1001/archneurol.2008.582
26. Fotenos, A. F., Mintun, M. A., Snyder, A. Z., Morris, J. C., and Buckner, R. L. (2008). Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch. Neurol. 65, 113-120. doi: 10.1001/archneurol.2007.27
27. Franke, K., Gaser, C., and For the Alzheimer's Disease Neuroimaging Initiative. (2012a). Longitudinal changes in individual BrainAGE in healthy aging, mild cognitive impairment, and Alzheimer's disease. GeroPsych J. Gerontopsychol. Geriatr. Psychiatry 25, 235-245. doi: 10.1024/1662-9647/a000074
28. Franke, K., Gaser, C., Manor, B., and Novak, V. (2013). Advanced BrainAGE in older adults with type 2 diabetes mellitus. Front. Aging Neurosci. 5:90. doi: 10.3389/fnagi.2013.00090
29. Franke, K., Luders, E., May, A., Wilke, M., and Gaser, C. (2012b). Brain maturation: predicting individual BrainAGE in children and adolescents using structural MRI. Neuroimage 63, 1305-1312. doi: 10.1016/j.neuroimage.2012.08.001
30. Franke, K., Ziegler, G., Klöppel, S., Gaser, C., and The Alzheimer's Disease Neuroimaging Initiative (2010). Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters. Neuroimage 50, 883-892. doi: 10.1016/j.neuroimage.2010.01.005
31. Frisardi, V., Panza, F., Seripa, D., Imbimbo, B. P., Vendemiale, G., Pilotto, A., et al. (2010). Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J. Alzheimers. Dis. 22, 715-740. doi: 10.3233/JAD-2010-100942
32. Frisoni, G. B., Fox, N. C., Jack, C. R. Jr., Scheltens, P., and Thompson, P. M. (2010). The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol. 6, 67-77. doi: 10.1038/nrneurol.2009.215
33. Gaser, C. (2009). Partial volume segmentation with Adaptive Maximum a Posteriori (MAP) approach. Neuroimage 47, S121. doi: 10.1016/S1053-8119(09)71151-6
34. Gaser, C., Franke, K., Kloppel, S., Koutsouleris, N., and Sauer, H. (2013). BrainAGE in mild cognitive impaired patients: predicting the conversion to Alzheimer's disease. PLoS ONE 8:e67346. doi: 10.1371/journal.pone.0067346
35. Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N., Friston, K. J., and Frackowiak, R. S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21-36. doi: 10.1006/nimg.2001.0786
36. Grossi, E., Massini, G., Buscema, M., Savare, R., and Maurelli, G. (2005). Two different Alzheimer diseases in men and women: clues from advanced neural networks and artificial intelligence. Gend. Med. 2, 106-117. doi: 10.1016/S1550-8579(05)80017-8
37. Gu, Y., Nieves, J. W., Stern, Y., Luchsinger, J. A., and Scarmeas, N. (2010). Food combination and Alzheimer disease risk: a protective diet. Arch. Neurol. 67, 699-706. doi: 10.1001/archneurol.2010.84
38. Hinterberger, M., and Fischer, P. (2013). Folate and Alzheimer: when time matters. J. Neural Transm. 120, 211-224. doi: 10.1007/s00702-012-0822-y
39. Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6, 65-70.
40. Hughes, T. F., and Ganguli, M. (2009). Modifiable midlife risk factors for late-life cognitive impairment and dementia. Curr. Psychiatry Rev. 5, 73-92. doi: 10.2174/157340009788167347
41. Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128. doi: 10.1016/S1474-4422(09)70299-6
42. Jones, D. T., Machulda, M. M., Vemuri, P., McDade, E. M., Zeng, G., Senjem, M. L., et al. (2011). Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology 77, 1524-1531. doi: 10.1212/WNL.0b013e318233b33d
43. Kim, G., Kim, H., Kim, K. N., Son, J. I., Kim, S. Y., Tamura, T., et al. (2013). Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey. J. Alzheimers. Dis. 33, 853-862. doi: 10.3233/JAD-2012-121345
44. Langan, R. C., and Zawistoski, K. J. (2011). Update on vitamin B12 deficiency. Am. Fam. Physician 83, 1425-1430.
45. Lebel, C., and Beaulieu, C. (2011). Longitudinal development of human brain wiring continues from childhood into adulthood. J. Neurosci. 31, 10937-10947. doi: 10.1523/JNEUROSCI.5302-10.2011
46. Lenroot, R. K., and Giedd, J. N. (2006). Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci. Biobehav. Rev. 30, 718-729. doi: 10.1016/j.neubiorev.2006.06.001
47. Luchsinger, J. A., and Gustafson, D. R. (2009). Adiposity and Alzheimer's disease. Curr. Opin. Clin. Nutr. Metab. Care 12, 15-21. doi: 10.1097/MCO.0b013e32831c8c71
48. Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., and Mayeux, R. (2005). Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545-551. doi: 10.1212/01.wnl.0000172914.08967.dc
49. Mangialasche, F., Westman, E., Kivipelto, M., Muehlboeck, J. S., Cecchetti, R., Baglioni, M., et al. (2013). Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of alpha-/gamma-tocotrienols and gamma-tocopherol. J. Intern. Med. 273, 602-621. doi: 10.1111/joim.12037
50. McMahon, J. A., Green, T. J., Skeaff, C. M., Knight, R. G., Mann, J. I., and Williams, S. M. (2006). A controlled trial of homocysteine lowering and cognitive performance. N. Engl. J. Med. 354, 2764-2772. doi: 10.1056/NEJMoa054025
51. Middleton, L. E., and Yaffe, K. (2009). Promising strategies for the prevention of dementia. Arch. Neurol. 66, 1210-1215. doi: 10.1001/archneurol.2009.201
52. Mohs, R. C. (1996). The Alzheimer's Disease Assessment Scale. Int. Psychogeriatr. 8, 195-203. doi: 10.1017/S1041610296002578
53. Mohs, R. C., and Cohen, L. (1988). Alzheimer's disease assessment scale (ADAS). Psychopharmacol. Bull. 24, 627-628.
54. Morris, J. C. (1993). The clinical dementia rating (CDR): current version and scoring rules. Neurology 43, 2412-2414. doi: 10.1212/WNL.43.11.2412-a
55. Morris, M. S. (2012). The role of B vitamins in preventing and treating cognitive impairment and decline. Adv. Nutr. 3, 801-812. doi: 10.3945/an.112.002535
56. Morris, M. S., Selhub, J., and Jacques, P. F. (2012). Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. J. Am. Geriatr. Soc. 60, 1457-1464. doi: 10.1111/j.1532-5415.2012.04076.x
57. Nepal, B., Brown, L., and Ranmuthugala, G. (2010). Modelling the impact of modifying lifestyle risk factors on dementia prevalence in Australian population aged 45 years and over, 2006-2051. Australas. J. Ageing 29, 111-116. doi: 10.1111/j.1741-6612.2010.00392.x
58. Oulhaj, A., Refsum, H., Beaumont, H., Williams, J., King, E., Jacoby, R., et al. (2010). Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int. J. Geriatr. Psychiatry 25, 82-90. doi: 10.1002/gps.2303
59. Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L., and Bulpitt, C. (2008). Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 8:36. doi: 10.1186/1471-2318-8-36
60. Pfefferbaum, A., Mathalon, D. H., Sullivan, E. V., Rawles, J. M., Zipursky, R. B., and Lim, K. O. (1994). A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch. Neurol. 51, 874-887. doi: 10.1001/archneur.1994.00540210046012
61. Pinn, V. W. (2003). Sex and gender factors in medical studies: implications for health and clinical practice. JAMA 289, 397-400. doi: 10.1001/jama.289.4.397
62. Querbes, O., Aubry, F., Pariente, J., Lotterie, J. A., Demonet, J. F., Duret, V., et al. (2009). Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 132, 2036-2047. doi: 10.1093/brain/awp105
63. Rajapakse, J. C., Giedd, J. N., and Rapoport, J. L. (1997). Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans. Med. Imaging 16, 176-186. doi: 10.1109/42.563663
64. Raz, N., and Rodrigue, K. M. (2006). Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci. Biobehav. Rev. 30, 730-748. doi: 10.1016/j.neubiorev.2006.07.001
65. Resnick, S. M., Pham, D. L., Kraut, M. A., Zonderman, A. B., and Davatzikos, C. (2003). Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci. 23, 3295-3301.
66. Saetre, P., Jazin, E., and Emilsson, L. (2011). Age-related changes in gene expression are accelerated in Alzheimer's disease. Synapse 65, 971-974. doi: 10.1002/syn.20933
67. Scarmeas, N., Luchsinger, J. A., Schupf, N., Brickman, A. M., Cosentino, S., Tang, M. X., et al. (2009). Physical activity, diet, and risk of Alzheimer disease. J. Am. Med. Assoc. 302, 627-637. doi: 10.1001/jama.2009.1144
68. Schölkopf, B., and Smola, A. (2002). Learning with Kernels: Support Vector Machines, Regularization, Optimization, and Beyond. Cambridge, MA: MIT Press.
69. Sluimer, J. D., Van Der Flier, W. M., Karas, G. B., Van Schijndel, R., Barnes, J., Boyes, R. G., et al. (2009). Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. Eur. Radiol. 19, 2826-2833. doi: 10.1007/s00330-009-1512-5
70. Snowdon, D. A. (2003). Healthy aging and dementia: findings from the Nun Study. Ann. Intern. Med. 139, 450-454. doi: 10.7326/0003-4819-139-5_Part_2-200309021-00014
71. Solfrizzi, V., Capurso, C., D'introno, A., Colacicco, A. M., Santamato, A., Ranieri, M., et al. (2008). Lifestyle-related factors in predementia and dementia syndromes. Expert Rev. Neurother. 8, 133-158. doi: 10.1586/14737175.8.1.133
72. Spulber, G., Niskanen, E., Macdonald, S., Smilovici, O., Chen, K., Reiman, E. M., et al. (2010). Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease. Neurobiol. Aging 31, 1601-1605. doi: 10.1016/j.neurobiolaging.2008.08.018
73. Steele, M., Stuchbury, G., and Munch, G. (2007). The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp. Gerontol. 42, 28-36. doi: 10.1016/j.exger.2006.06.002
74. Taki, Y., Kinomura, S., Sato, K., Inoue, K., Goto, R., Okada, K., et al. (2008). Relationship between body mass index and gray matter volume in 1, 428 healthy individuals. Obesity (Silver Spring) 16, 119-124. doi: 10.1038/oby.2007.4
75. Terribilli, D., Schaufelberger, M. S., Duran, F. L., Zanetti, M. V., Curiati, P. K., Menezes, P. R., et al. (2011). Age-related gray matter volume changes in the brain during non-elderly adulthood. Neurobiol. Aging 32, 354-368. doi: 10.1016/j.neurobiolaging.2009.02.008
76. Tipping, M. E. (2001). Sparse bayesian learning and the relevance vector machine. J. Mach. Learn. Res. 1, 211-244. doi: 10.1162/15324430152748236
77. Tohka, J., Zijdenbos, A., and Evans, A. (2004). Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage 23, 84-97. doi: 10.1016/j.neuroimage.2004.05.007
78. Wang, P. N., Liu, H. C., Lirng, J. F., Lin, K. N., and Wu, Z. A. (2009). Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment. Psychiatry Res. 171, 221-231. doi: 10.1016/j.pscychresns.2008.05.002
79. Wilke, M., Schmithorst, V. J., and Holland, S. K. (2003). Normative pediatric brain data for spatial normalization and segmentation differs from standard adult data. Magn. Reson. Med. 50, 749-757. doi: 10.1002/mrm.10606
80. Xu, G., Liu, X., Yin, Q., Zhu, W., Zhang, R., and Fan, X. (2009). Alcohol consumption and transition of mild cognitive impairment to dementia. Psychiatry Clin. Neurosci. 63, 43-49. doi: 10.1111/j.1440-1819.2008.01904.x
81. Zylberstein, D. E., Lissner, L., Bjorkelund, C., Mehlig, K., Thelle, D. S., Gustafson, D., et al. (2011). Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol. Aging 32, 380-386. doi: 10.1016/j.neurobiolaging.2009.02.024